Comorbidities of COPD

被引：2
作者：
Watz H. [1 ]
Magnussen H. [1 ,2 ]
机构：
[1] Krankenhaus Großhansdorf, Zentrum für Pneumologie und Thoraxchirurgie, Pneumologisches Forschungsinstitut Am Krankenhaus Großhansdorf
[2] Krankenhaus Großhansdorf, Zentrum für Pneumologie und Thoraxchirurgie, 22927 Großhansdorf
来源：
Der Internist | 2006年 / 47卷 / 9期
关键词：
Cardiovascular mortality; Chronic obstructive pulmonary disease; Comorbidities; COPD;
D O I：
10.1007/s00108-006-1675-y
中图分类号：
学科分类号：
摘要：
Chronic obstructive pulmonary disease (COPD) is often associated with comorbidities. Cardiovascular diseases, weight loss, loss of fat free mass combined with muscle dysfunction, osteoporosis and depression are the main comorbidities in COPD. Cardiovascular comorbidities, weight loss and loss of fat free mass are predictors of mortality of patients with COPD. Thus, the extrapulmonary manifestations are meaningful parameters of clinical assessment. Systemic inflammation is probably the key to the extrapulmonary signs of COPD. © Springer Medizin Verlag 2006.
引用
收藏
页码：895 / 900
页数：5
相关论文
共 27 条
  • [1] Agusti A.G., Noguera A., Sauleda J., Et al., Systemic effects of chronic obstructive pulmonary disease, Eur Respir J, 21, pp. 347-360, (2003)
  • [2] Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society, Am J Respir Crit Care Med, 159, (1999)
  • [3] Celli B.R., Macnee W., Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper, Eur Respir J, 23, pp. 932-946, (2004)
  • [4] Chaouat A., Bugnet A.S., Kadaoui N., Et al., Severe pulmonary hypertension and chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 172, pp. 189-194, (2005)
  • [5] Engstrom G., Lind P., Hedblad B., Et al., Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins, Circulation, 106, pp. 2555-2560, (2002)
  • [6] Gan W.Q., Man S.F., Senthilselvan A., Sin D.D., Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis, Thorax, 59, pp. 574-580, (2004)
  • [7] Hogg J.C., Chu F., Utokaparch S., Et al., The nature of small-airway obstruction in chronic obstructive pulmonary disease, N Engl J Med, 350, pp. 2645-2653, (2004)
  • [8] Ionescu A.A., Schoon E., Osteoporosis in chronic obstructive pulmonary disease, Eur Respir J, 46, SUPPL., (2003)
  • [9] Landbo C., Prescott E., Lange P., Et al., Prognostic value of nutritional status in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 160, pp. 1856-1861, (1999)
  • [10] Maccallum P.K., Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers, Proc Am Thorac Soc, 2, pp. 34-43, (2005)
123